[SCHEDULE 13G/A] Kintara Therapeutics, Inc. Common Stock SEC Filing

Rhea-AI Filing Summary

TuHURA Biosciences, Inc. reported that CA Patel F&F Investments, LLC beneficially owned 447,232 shares of the companys common stock as of June 12, 2025. That holding represents 0.9% of the outstanding class, calculated using 50,046,926 shares reported by the issuer as outstanding on August 11, 2025. The filing states the reporting person has sole voting and dispositive power over all 447,232 shares and that the shares were not acquired to influence control of the company.

The Schedule 13G/A provides the filers business address in Tampa, Florida, and is signed by Adam Baals as Manager of CA Patel F&F Investments, LLC on August 14, 2025.

Positive

• Transparent disclosure of beneficial ownership and voting/dispositive powers
• Position clearly characterized as passive, not acquired to influence control

Negative

• None.

Insights

Financial Analyst

TL;DR: Passive stake disclosed; <0.9% ownership is immaterial to control or valuation.

The filing documents a small, passive position of 447,232 shares, equal to 0.9% of TuHURAs outstanding common stock based on the issuers reported share count. For investors, a sub-1% position typically indicates no near-term influence on corporate strategy or control. The declaration of sole voting and dispositive power clarifies voting responsibility but does not imply coordination with other holders. This disclosure improves transparency but is unlikely to move market perceptions absent further accumulation or related filings.

Corporate Governance Expert

TL;DR: Governance impact is minimal; filing affirms passive intent and voting authority.

The Schedule 13G/A explicitly states the securities were not acquired to influence control and includes the certificate that the position is passive. The reporters sole voting and dispositive power is noted, which is important for vote-tracking, but a 0.9% stake does not create practical governance influence. The timely amendment and signature by the manager satisfy disclosure obligations under the Exchange Act.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

TuHURA Biosciences, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

898920103

(CUSIP Number)

06/12/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 898920103

1

Names of Reporting Persons

CA Patel F&F Investments, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 447,232.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 447,232.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

447,232.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.9 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Includes (i) 447,232 shares of common stock, par value $0.001 per share ("Common Stock"), of the Issuer. * Percent of class is calculated based on 50,046,926 shares of Common Stock outstanding as of August 11, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on August 14, 2025. The percentage of ownership was calculated in accordance with Rule 13d-3(d)(1)(i) promulgated under the Securities Exchange Act of 1934, as amended.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: TuHURA Biosciences, Inc.
(b)	Address of issuer's principal executive offices: 10500 University Drive, Suite 110, Tampa, Florida, 33612
Item 2.
(a)	Name of person filing: CA Patel F&F Investments, LLC
(b)	Address or principal business office or, if none, residence: The business address of the Reporting Person is 5600 Mariner St., Ste. 200, Tampa, FL 33609.
(c)	Citizenship: CA Patel F&F Investments, LLC is a Florida limited liability company.
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 898920103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Amount Beneficially Owned: As of June 12, 2025, the Reporting Person beneficially owns 447,232 shares of Common Stock, representing less than 5% of the class outstanding.
(b)	Percent of class: Percent of Class: 0.9%. Percent of class is calculated based on 50,046,926 shares of Common Stock of the Issuer outstanding as of August 11, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on August 14, 2025. The percentage of ownership in this Item 4 was calculated in accordance with Rule 13d-3(d)(1)(i) promulgated under the Securities Exchange Act of 1934, as amended.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 447,232
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 447,232
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

CA Patel F&F Investments, LLC

Signature:	/s/ Adam Baals
Name/Title:	Adam Baals, Manager
Date:	08/14/2025

FAQ

Who filed the Schedule 13G/A for TuHURA Biosciences (issuer)?

The filing was made by CA Patel F&F Investments, LLC with business address 5600 Mariner St., Ste. 200, Tampa, FL 33609.

How many TuHURA shares does CA Patel F&F Investments, LLC beneficially own?

447,232 shares of common stock as of June 12, 2025.

What percentage of TuHURA's common stock does the reported stake represent?

The stake represents 0.9% of the class, calculated using 50,046,926 shares outstanding reported as of August 11, 2025.

Does the filer have voting or dispositive control over the shares?

Yes, the filer reports sole voting power and sole dispositive power over all 447,232 shares.

Was the position acquired to influence control of TuHURA?

No. The certification states the securities were not acquired to change or influence control of the issuer.